Correction: Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2) 16 de October de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3 10 de July de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway 13 de May de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy 27 de April de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration 5 de April de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis 29 de March de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma 27 de March de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: SITC clinical Immuno-Oncology network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials 27 de March de 2024 by Journal for ImmunoTherapy of Cancer current issue
Correction: Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma 6 de March de 2024 by Journal for ImmunoTherapy of Cancer current issue